The metabolic behavior of obese individuals who do not have AT insulin resistance is similar to that of lean individuals, with near-normal muscle insulin sensitivity; hence this group of obese individuals usually does not develop NAFLD [93]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.